Stay Informed on Corporate Sustainability

Author: Jed Nykolle Harme

Matt Moran, CEO of Matt Moran Consulting, joins the judging panel of the Pharma Industry Awards 2025 as Judging Coordinator, bringing more than 30 years of leadership in the biopharmaceutical sector.

Author: Caixin Global

China’s Zhongguancun Life Science Park in Beijing is transforming pharma innovation, hosting over 1,000 companies and R&D institutes. The hub advances cell and gene therapies, neuroscience, AI healthcare, and first-in-class drugs.

Author: Global Bio Defense

The UK bolsters its life sciences leadership with Moderna’s £1BN Innovation and Technology Centre in Harwell and a £50M public R&D fund, enhancing mRNA innovation, pandemic preparedness, and biomedical sector growth.

Author: Irish Tech News

Alexion, AstraZeneca Rare Disease has expanded in Cork, enhancing Ireland’s life sciences hub by boosting research, talent development, and supply chain operations to advance therapies for rare disease patients globally.

Author: Logistics Manager

DHL Supply Chain is investing £550 million to scale automation, robotics, and healthcare logistics across the UK and Ireland. The move strengthens supply chain resilience, supports high-growth industries, and aligns with the UK’s trade strategy.

Author: Irish Legal News

Mason Hayes & Curran has launched Capsule, new digital platform providing regulatory insights and sector-specific updates for life sciences companies. The resource supports compliance, risk management and growth in an increasingly complex EU and global market.

Author: Jed Nykolle Harme

To support our clients with changing pharmacopoeial requirements, SGS ISL is introducing Polarised Light Microscopy to complement our existing XRPD for the introduction of raw material Asbestos testing in December 2025.

Author: Jed Nykolle Harme

Pharmaceutical companies are facing mounting challenges in meeting regulatory demands, accelerating product development and overcoming workforce shortages. To address these pressures, SGS is expanding its agile insourcing programme, embedding skilled scientific staff directly within client facilities.

Author: Jed Nykolle Harme

The Pharma Industry Awards 2025 has unveiled its shortlist, marking a pivotal moment in Ireland’s pharmaceutical calendar. Now in its 12th year, the programme stands as the country’s most prestigious celebration of excellence, innovation, and leadership across the life sciences.

Author: Jed Nykolle Harme

Pharma and life sciences remain at the forefront of global transformation, with resilience, innovation and agility emerging as the defining features of the sector’s growth. This edition highlights how excellence and adaptability are shaping both operations and outcomes, offering lessons well beyond healthcare. The Pharma Industry Awards has unveiled its shortlist, marking a pivotal moment in Ireland’s pharmaceutical calendar and underlining its role as a leading platform for recognising achievement. Operational strategy is equally significant, as SGS expands agile insourcing solutions, demonstrating how efficiency, scale and flexibility can safeguard competitiveness in a shifting market and meet growing global demand. Investor sentiment remains another crucial indicator. Atai Life Sciences hitting a 52-week high showcases confidence in innovation-led growth, underscoring the sector’s ability to capture capital, drive momentum and convert research investment into tangible results. These stories illustrate a sector not simply responding to challenges but actively reshaping them into opportunities. For leaders, the lesson is clear: excellence in standards, strategic agility, and innovation-driven sustainability are the cornerstones of long-term success and global impact.